See reviews below to learn more or submit your own review. How do I know I can trust these reviews about Jared The Galleria Of Jewelry? How do I know I can trust these reviews about Jared The ...
Google Maps is one of the most useful navigational tools on Android. It enables people to preview a trip and plan for obstacles. However, knowing how to find where you are right now on the map is ...
In other Mirum Pharmaceuticals news, CEO Christopher Peetz sold 7,489 shares of the company’s stock in a transaction dated Tuesday, January 7th. The shares were sold at an average price of $42. ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) reported Q1 EPS of ($1.17), $0.17 better than the analyst estimate of ($1.34). Revenue ...
Luke Herrmann; Analyst; Robert W. Baird & Co., Inc. Hello, and welcome to Mirum Pharmaceuticals reports fourth quarter and year-end 2024 financial results and provides business update. My name is ...
Luke Herrmann; Analyst; Robert W. Baird & Co., Inc. Hello, and welcome to Mirum Pharmaceuticals reports fourth quarter and year-end 2024 financial results and provides business update. My name is ...
Mirum Pharmaceuticals, Inc. (MIRM) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.66 per share a year ago.
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for the fourth quarter and year-end 2024 and provided a business update.
A MAP has revealed if you are considered rich based on where you live, after a new report found nine in 10 Brits who make £100k a year don't consider themselves wealthy. The new findings from ...
In this article, we are going to take a look at where Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) stands against other best performing mid cap stocks to buy according to analysts. On February 7 ...